As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
7 Themes to watch in 2024
February 4, 2024 2:00 PM ESTGoldman Sachs recently released its January update, presenting the "Top Themes" that their analysts believe investors should watch in 2024. Alongside this, the equity research firm made notable changes to its Conviction List, adding Parker Hannifan (NYSE: PH) and Textron (NYSE: TXT) while removing Bath & Body Works (NYSE: BBWI), Boeing (NYSE: BA), Shift4 Payments (NYSE: FOUR), and AIG (NYSE: AIG).
The Conviction List is Goldman Sachs' strategic approach to identifying... More
Novo Nordisk (NVO) gains as 2023 sales rise 31%
January 31, 2024 9:43 AM ESTNovo Nordisk (NYSE: NVO) shares gained more than 4% Wednesday after the company reported its latest quarterly and full-year 2023 earnings.
The company said sales increased by 31% in Danish kroner (DKK) to DKK 232.3 billion in 2023. Meanwhile, operating profit increased by 37% to DKK 102.6 billion.
"We... More
